Growth of $10,000 in IBB
iShares Biotechnology ETF · iShares
A $10,000 investment compounding at IBB’s trailing 10-year annualized total return of 7.4% would reach $41,929 in 20 years. The table shows every combination of averaging period and horizon; returns include dividends and are net of the fund's 0.44% expense ratio. Past performance does not predict future results.
Projection table
| Horizon | At 3-year avg (16.4%) | At 5-year avg (3.1%) | At 10-year avg (7.4%) |
|---|---|---|---|
| 5 years | $21,331 | $11,638 | $14,310 |
| 10 years | $45,503 | $13,544 | $20,477 |
| 15 years | $97,063 | $15,762 | $29,301 |
| 20 years | $207,050 | $18,344 | $41,929 |
| 25 years | $441,665 | $21,348 | $59,998 |
| 30 years | $942,131 | $24,845 | $85,855 |
Annualized total returns as of Aug 7, 2026, dividends reinvested. A constant rate is an illustration of compounding — real markets are far bumpier.
Want a different amount, horizon or a side-by-side fund comparison? Open IBB in the interactive calculator →
Frequently Asked Questions
What would $10,000 in IBB be worth in 10 years?
Compounding at its trailing 10-year annualized return of 7.4%, $10,000 in IBB would grow to about $20,477 in 10 years and $41,929 in 20 years. Real returns arrive unevenly, so treat this as an illustration of compounding, not a forecast.
What is IBB's average annual return?
As of Aug 7, 2026, IBB's annualized total returns were 16.4% over 3 years, 3.1% over 5 years, 7.4% over 10 years — dividends reinvested, net of its 0.44% expense ratio.